Ethyl 2,4-Dioxo-4-Phenylbutanoate

Ethyl 2,4-dioxo-4-phenylbutanoate has several applications:

• Pharmaceuticals: Due to its Src kinase inhibitory activity, it holds potential as a therapeutic agent in cancer treatment.
• Synthesis of Derivatives: It serves as a versatile intermediate for synthesizing various enantiomerically pure α-hydroxy and α-amino acid esters, which are valuable in drug development.

Research indicates that ethyl 2,4-dioxo-4-phenylbutanoate exhibits moderate Src kinase inhibitory activity. This property is essential as Src kinases are implicated in various cellular processes, including proliferation and survival. The compound's activity was evaluated against several derivatives, showing that substitutions on the aromatic ring can significantly influence its efficacy.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.